CDH1 and cancer: Immunofluorescence analysis revealed that AOM-treated tissues exhibited altered E-cadherin localization, with increased cytoplasmic and nuclear accumulation, indicative of epithelial-to-mesenchymal transition (EMT), a process associated with cancer progression.